PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
23840429-0	2013	Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pathways.	2-[piperidinoethoxyphenyl]-3-phenyl-2h-benzo(b)pyran	30-82	estrogen receptor 1	Homo sapiens	86-103
23840429-0	2013	Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pathways.	2-[piperidinoethoxyphenyl]-3-phenyl-2h-benzo(b)pyran	30-82	epidermal growth factor receptor	Homo sapiens	160-164
23840429-0	2013	Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pathways.	2-[piperidinoethoxyphenyl]-3-phenyl-2h-benzo(b)pyran	30-82	AKT serine/threonine kinase 1	Homo sapiens	210-213
23840429-0	2013	Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pathways.	2-[piperidinoethoxyphenyl]-3-phenyl-2h-benzo(b)pyran	30-82	mitogen-activated protein kinase kinase 7	Homo sapiens	223-226
23840429-0	2013	Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pathways.	2-[piperidinoethoxyphenyl]-3-phenyl-2h-benzo(b)pyran	30-82	mitogen-activated protein kinase 1	Homo sapiens	227-230
23840429-0	2013	Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pathways.	2-[piperidinoethoxyphenyl]-3-phenyl-2h-benzo(b)pyran	30-82	Fos proto-oncogene, AP-1 transcription factor subunit	Homo sapiens	231-235
23840429-2	2013	We have investigated here the anti-breast cancer properties of a novel anti-proliferative benzopyran compound namely, 2-[piperidinoethoxyphenyl]-3-phenyl-2H-benzo(b)pyran (CDRI-85/287) in ER- negative and EGFR- overexpressing breast cancer cells.	2-[piperidinoethoxyphenyl]-3-phenyl-2h-benzo(b)pyran	118-170	estrogen receptor 1	Homo sapiens	188-190
23840429-2	2013	We have investigated here the anti-breast cancer properties of a novel anti-proliferative benzopyran compound namely, 2-[piperidinoethoxyphenyl]-3-phenyl-2H-benzo(b)pyran (CDRI-85/287) in ER- negative and EGFR- overexpressing breast cancer cells.	2-[piperidinoethoxyphenyl]-3-phenyl-2h-benzo(b)pyran	118-170	epidermal growth factor receptor	Homo sapiens	205-209
32218596-0	2020	Retraction: Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pathways.	2-[piperidinoethoxyphenyl]-3-phenyl-2h-benzo(b)pyran	42-94	epidermal growth factor receptor	Homo sapiens	172-176
32218596-0	2020	Retraction: Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pathways.	2-[piperidinoethoxyphenyl]-3-phenyl-2h-benzo(b)pyran	42-94	AKT serine/threonine kinase 1	Homo sapiens	222-225
32218596-0	2020	Retraction: Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pathways.	2-[piperidinoethoxyphenyl]-3-phenyl-2h-benzo(b)pyran	42-94	mitogen-activated protein kinase kinase 7	Homo sapiens	235-238
32218596-0	2020	Retraction: Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pathways.	2-[piperidinoethoxyphenyl]-3-phenyl-2h-benzo(b)pyran	42-94	mitogen-activated protein kinase 1	Homo sapiens	239-242
32218596-0	2020	Retraction: Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pathways.	2-[piperidinoethoxyphenyl]-3-phenyl-2h-benzo(b)pyran	42-94	JunD proto-oncogene, AP-1 transcription factor subunit	Homo sapiens	243-247